Evofem Biosciences, Inc. is leading a New Era in Women’s Contraception, targeting a Multi-Billion Dollar Market Opportunity, with their revolutionary hormone-free contraceptive.

As the organic movement grows, society is trending in favor of more natural products and solutions. Women’s healthcare is no different. Many women are now opting for a non-hormonal, localized method of birth control.

Carmel Fisher interviews Amy Raskopf, EVFM’s Sr. Vice President of Investor Relations, and dives deeper into how the market is responding to this female revolution holding a current FDA approval.

Disclaimer:

The Harvest podcast is for informational and educational purposes only. The views and opinions expressed  ...